Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study

NCT05776147 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-03-07

No results posted yet for this study

Summary

The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.

Conditions

  • Radiotherapy Side Effect

Sponsors & Collaborators

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Gustavo Nader Marte · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-09
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05776147 on ClinicalTrials.gov